Companies

Wellgistics Health, Inc.

WGRX · CIK 0002030763 · operating

$0.23-2.75%Last updated Mar 2, 8:48 PM

Key Statistics

Valuation

Market Cap$23.75M
P/E
Fwd P/E
PEG
P/S0.70
P/B3.02
EV/EBITDA-0.65
EV/Rev1.32

Profitability

Gross Margin9.75%
Op. Margin-33.90%
Net Margin-37.82%
ROE-101.81%
ROA-11.96%
FCF Margin-6.76%

Financial Health

Current Ratio0.40
Debt/Equity7.51
Free Cash Flow-$1.22M
Div. Yield

Growth & Other

Revenue Growth
EPS Growth
Beta
52W High$7.04
52W Low$0.21

About Wellgistics Health, Inc.

# Wellgistics Health, Inc. (WGRX)

Wellgistics Health operates as a pharmaceutical wholesale distributor and logistics provider serving the U.S. market. The company distributes generic and branded pharmaceuticals alongside over-the-counter healthcare and consumer products to pharmaceutical manufacturers and independent retail pharmacies. Beyond distribution, Wellgistics provides third-party logistics services including warehousing, inventory management, order fulfillment, and shipping, primarily serving small and mid-size pharmaceutical manufacturers.

The company operates multiple business segments. Its DelivMeds platform functions as a pharmaceutical hub facilitating prescription transfers and delivering backend clinical concierge services to a network of independent pharmacies. Wellgistics also operates retail community pharmacy operations. These segments address different points in the pharmaceutical supply chain, from manufacturer support to end-user pharmacy services.

The company was incorporated in Delaware in 2022 and is headquartered in Tampa, Florida. It changed its name from Danam Health, Inc. to Wellgistics Health, Inc. in October 2024. The company trades on Nasdaq with a minimal market capitalization, indicating a small-cap enterprise. Specific details regarding employee count, annual revenue, or geographic distribution beyond the United States are not publicly available.

Earnings Per Share (Annual · SEC XBRL)

Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.

Fiscal YearEPS DilutedEPS BasicYoY
2024$-0.15$-0.15

Annual Reports (10-K) · 1 filings

Report DateFiledAccession Number
2024-12-312025-03-250001641172-25-000612SEC ↗